Annual EBITDA
-$390.12 M
+$43.18 M+9.97%
December 31, 2024
Summary
- As of March 13, 2025, GH annual EBITDA is -$390.12 million, with the most recent change of +$43.18 million (+9.97%) on December 31, 2024.
- During the last 3 years, GH annual EBITDA has fallen by -$30.50 million (-8.48%).
- GH annual EBITDA is now -889.60% below its all-time high of -$39.42 million, reached on December 31, 2016.
Performance
GH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$99.19 M
-$2.71 M-2.81%
December 31, 2024
Summary
- As of March 13, 2025, GH quarterly EBITDA is -$99.19 million, with the most recent change of -$2.71 million (-2.81%) on December 31, 2024.
- Over the past year, GH quarterly EBITDA has increased by +$76.88 million (+43.66%).
- GH quarterly EBITDA is now -1035.95% below its all-time high of -$8.73 million, reached on June 30, 2019.
Performance
GH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$390.12 M
+$76.88 M+16.46%
December 31, 2024
Summary
- As of March 13, 2025, GH TTM EBITDA is -$390.12 million, with the most recent change of +$76.88 million (+16.46%) on December 31, 2024.
- Over the past year, GH TTM EBITDA has increased by +$43.18 million (+9.97%).
- GH TTM EBITDA is now -1347.68% below its all-time high of -$26.95 million, reached on September 30, 2017.
Performance
GH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | +43.7% | +10.0% |
| 3 y3 years | -8.5% | +22.8% | +36.6% |
| 5 y5 years | -582.9% | +22.8% | +36.6% |
GH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.5% | +36.6% | -62.6% | +54.8% | -8.5% | +37.3% |
| 5 y | 5-year | -582.9% | +36.6% | -426.8% | +54.8% | -582.9% | +37.3% |
| alltime | all time | -889.6% | +36.6% | -1036.0% | +54.8% | -1347.7% | +37.3% |
Guardant Health EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$390.12 M(-10.0%) | -$99.19 M(+2.8%) | -$390.12 M(-16.5%) |
| Sep 2024 | - | -$96.48 M(+5.8%) | -$467.00 M(+5.1%) |
| Jun 2024 | - | -$91.23 M(-11.6%) | -$444.45 M(+7.3%) |
| Mar 2024 | - | -$103.22 M(-41.4%) | -$414.22 M(-4.4%) |
| Dec 2023 | -$433.31 M(-29.5%) | -$176.07 M(+138.2%) | -$433.31 M(+12.3%) |
| Sep 2023 | - | -$73.93 M(+21.2%) | -$385.75 M(-16.7%) |
| Jun 2023 | - | -$61.00 M(-50.1%) | -$463.25 M(-25.5%) |
| Mar 2023 | - | -$122.30 M(-4.8%) | -$621.81 M(+1.1%) |
| Dec 2022 | -$614.91 M(+71.0%) | -$128.52 M(-15.1%) | -$614.91 M(+11.4%) |
| Sep 2022 | - | -$151.43 M(-31.0%) | -$551.96 M(+10.0%) |
| Jun 2022 | - | -$219.56 M(+90.2%) | -$501.77 M(+34.4%) |
| Mar 2022 | - | -$115.41 M(+76.0%) | -$373.44 M(+3.8%) |
| Dec 2021 | -$359.62 M | -$65.57 M(-35.2%) | -$359.62 M(-4.7%) |
| Sep 2021 | - | -$101.24 M(+11.0%) | -$377.50 M(+9.9%) |
| Jun 2021 | - | -$91.22 M(-10.2%) | -$343.50 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$101.59 M(+21.8%) | -$298.17 M(+32.5%) |
| Dec 2020 | -$225.07 M(+294.0%) | -$83.44 M(+24.1%) | -$225.07 M(+40.3%) |
| Sep 2020 | - | -$67.24 M(+46.5%) | -$160.46 M(+52.9%) |
| Jun 2020 | - | -$45.89 M(+61.0%) | -$104.91 M(+54.8%) |
| Mar 2020 | - | -$28.50 M(+51.3%) | -$67.75 M(+18.6%) |
| Dec 2019 | -$57.13 M(-24.7%) | -$18.83 M(+61.0%) | -$57.13 M(-6.4%) |
| Sep 2019 | - | -$11.69 M(+33.9%) | -$61.07 M(-13.5%) |
| Jun 2019 | - | -$8.73 M(-51.2%) | -$70.58 M(-13.5%) |
| Mar 2019 | - | -$17.88 M(-21.5%) | -$81.60 M(+7.6%) |
| Dec 2018 | -$75.84 M(+0.7%) | -$22.77 M(+7.4%) | -$75.84 M(+14.2%) |
| Sep 2018 | - | -$21.20 M(+7.3%) | -$66.43 M(-8.0%) |
| Jun 2018 | - | -$19.75 M(+63.0%) | -$72.17 M(+37.7%) |
| Mar 2018 | - | -$12.12 M(-9.3%) | -$52.42 M(+30.1%) |
| Dec 2017 | -$75.31 M(+91.0%) | -$13.36 M(-50.4%) | -$40.30 M(+49.6%) |
| Sep 2017 | - | -$26.95 M | -$26.95 M |
| Dec 2016 | -$39.42 M | - | - |
FAQ
- What is Guardant Health annual EBITDA?
- What is the all time high annual EBITDA for Guardant Health?
- What is Guardant Health annual EBITDA year-on-year change?
- What is Guardant Health quarterly EBITDA?
- What is the all time high quarterly EBITDA for Guardant Health?
- What is Guardant Health quarterly EBITDA year-on-year change?
- What is Guardant Health TTM EBITDA?
- What is the all time high TTM EBITDA for Guardant Health?
- What is Guardant Health TTM EBITDA year-on-year change?
What is Guardant Health annual EBITDA?
The current annual EBITDA of GH is -$390.12 M
What is the all time high annual EBITDA for Guardant Health?
Guardant Health all-time high annual EBITDA is -$39.42 M
What is Guardant Health annual EBITDA year-on-year change?
Over the past year, GH annual EBITDA has changed by +$43.18 M (+9.97%)
What is Guardant Health quarterly EBITDA?
The current quarterly EBITDA of GH is -$99.19 M
What is the all time high quarterly EBITDA for Guardant Health?
Guardant Health all-time high quarterly EBITDA is -$8.73 M
What is Guardant Health quarterly EBITDA year-on-year change?
Over the past year, GH quarterly EBITDA has changed by +$76.88 M (+43.66%)
What is Guardant Health TTM EBITDA?
The current TTM EBITDA of GH is -$390.12 M
What is the all time high TTM EBITDA for Guardant Health?
Guardant Health all-time high TTM EBITDA is -$26.95 M
What is Guardant Health TTM EBITDA year-on-year change?
Over the past year, GH TTM EBITDA has changed by +$43.18 M (+9.97%)